TITLE

Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection

AUTHOR(S)
Missale, Gabriele; Pilli, Massimo; Zerbini, Alessandro; Penna, Amalia; Ravanetti, Lara; Barili, Valeria; Orlandini, Alessandra; Molinari, Atim; Fasano, Massimo; Santantonio, Teresa; Ferrari, Carlo
PUB. DATE
July 2012
SOURCE
Gut;Jul2012, Vol. 61 Issue 7, p1076
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Hepatitis C virus (HCV) persistence is associated with impaired CD8 functions. Whether functional restoration of CD8 T cells chronically exposed to antigen can be obtained once the antigen is removed remains to be clarified. Objective: To determine whether clearance of HCV by antiviral treatment can fully restore the antiviral function of HCV-specific CD8 cells. Design: Peripheral blood HCV-, Flu- and cytomegalovirus (CMV)-specific CD8 cells were quantified by tetramer staining in 28 patients whose HCV infection resolved after peginterferon or peginterferon/ribavirin treatment for either acute or chronic hepatitis and in eight subjects with acute HCV infection which resolved spontaneously for comparison. HCV-specific CD8 cells were evaluated for their phenotypic and functional characteristics by comparing different patient groups and CD8 cells with different viral specificities in the same patients. Results: Sustained viral response (SVR) did not lead to full maturation of a functional memory CD8 cell response. In particular, SVR in chronic infection was associated with a greater level of T cell dysfunction than responders after acute infection, who showed HCV-specific CD8 responses comparable to those of spontaneous resolvers but weaker than those of Flu-specific CD8 cells. Higher programmed death (PD)-1 expression was detected on HCV than on Flu- and CMV-specific CD8 cells and the effect of PD-1/PD-L1 blockade was better in SVRs after chronic than after acute HCV infection. Conclusion: A better restoration of HCV-specific CD8 function was detectable after SVR in patients with acute hepatitis than in those with chronic disease. Thus, the difficulty in achieving a complete restoration of the antiviral T cell function should be considered in the design of immunomodulatory therapies. INSET: Significance of this study.
ACCESSION #
76169844

 

Related Articles

  • Therapy of Acute Hepatitis C: A Review of Literature. Santantonio, T.; Fasano, M. // Current Pharmaceutical Design;Jun2008, Vol. 14 Issue 17, p1686 

    The goal of treatment for acute hepatitis C patients is to eradicate the virus in the early phase of infection, thus preventing progression to chronicity. Early interferon (IFN) monotherapy has been shown to significantly reduce this risk, and therefore it has been recommended by international...

  • DAA regimen yielded high SVR rates without ribavirin.  // Infectious Disease News;Jun2014, Vol. 27 Issue 6, p31 

    The article reports on a finding from the PEARL-II study which states that a three direct-acting antivirals regimen had showed high rates of sustained virologic response in patients with hepatitis C virus genotype 1b infection.

  • Approaches to hepatitis C treatment and cure using NS5A inhibitors. Kohler, James J.; Nettles, James H.; Amblard, Franck; Hurwitz, Selwyn J.; Bassit, Leda; Stanton, Richard A.; Ehteshami, Maryam; Schinazi, Raymond F. // Infection & Drug Resistance;2014, Vol. 7, p41 

    Recent progress in the understanding of hepatitis C virus (HCV) biology and the availability of in vitro models to study its replication have facilitated the development of direct-acting antiviral agents (DAAs) that target specific steps in the viral replication cycle. Currently, there are three...

  • Concordance of sustained virologic response at weeks 4, 12 and 24 post-treatment of hepatitis C in the era of new oral direct-acting antivirals: A concise review. Burgess, Sarah V.; Hussaini, Trana; Yoshida, Eric M. // Annals of Hepatology: Official Journal of the Mexican Associatio;Mar/Apr2016, Vol. 15 Issue 2, p154 

    The goal of treatment for chronic hepatitis C viral (HCV) infection is to cure the infection rather than suppress the virus. Historically, a sustained virological response (SVR) defined as undetectable HCV RNA at 24 weeks following the completion of treatment was considered the gold standard to...

  • Emerging Therapeutic Strategies for Hepatitis C Virus Infection. Sato, Ken; Takagi, Hitoshi; Ichikawa, Takeshi; Kakizaki, Satoru; Mori, Masatomo // Current Molecular Pharmacology;Jun2008, Vol. 1 Issue 2, p130 

    The universal prevalence of hepatitis C virus (HCV) infection, which causes chronic hepatitis, cirrhosis, liver failure, and hepatocellular carcinoma, has become a significant health problem worldwide. Interferon-based therapies, the current standard, IFN-based therapies have limited efficacy...

  • Treatment of Hepatitis C Virus Infection-Is There Progress? Ruef, C. // Infection;Feb2005, Vol. 33 Issue 1, p1 

    Comments on progress in the treatment of hepatitis c virus (HCV) infection. Use of peginterferon alfa-2b; Instrument sterility in the health-care settings; Reasons for nonparticipation in the treatment; Reason why treatment of HCV infection in intravenous drug users was not feasible.

  • Hepatitis C Treatment in Patients with Drug Addiction: Clinical Management of Interferon-Alpha-Associated Psychiatric Side Effects. Schaefer, Martin; Mauss, Stefan // Current Drug Abuse Reviews;Jun2008, Vol. 1 Issue 2, p177 

    60-90% of patients with intravenous drug abuse are chronically infected with the hepatitis C virus (HCV). Antiviral treatment with pegylated interferon-alfa (IFN-α) plus ribavirin is often complicated by psychiatric adverse events, significantly affecting patients adherence. Depression,...

  • The markers predicting response to Hepatitis C virus treatment and evaluation of treatment responses. G�nal, �zg�r; Barut, H�seyin Sener; Erkorkmaz, �nal // Journal of Microbiology & Infectious Diseases;Sep2012, Vol. 2 Issue 3, p100 

    Objectives: Currently pegylated interferon alpha (peg-IFN) and ribavirin treatment is recommended for chronic hepatitis C treatment. The aim of treatment is to provide sustained viral response (SVR). Material and methods: A total of 125 patients, who have been treated for chronic hepatitis C...

  • Efficiency of Chronic Hepatitis C Therapy with Pegylated Interferon and Ribavirin using Microsoft SQL Server. PAPACHRISTOS, Vasileios; ACHIMAS-CADARIU, Andrei; DRACOULIS, Christos // Applied Medical Informatics;Dec2012, Vol. 31 Issue 4, p21 

    Aim: The most effective treatment for patients with chronic hepatitis C virus infection is pegylated interferon (PegIFNa) and Ribavirin combination therapy. The aim of this study was to examine the effect of PegIFN and Ribavirin combination therapy in patients infected with hepatitis C virus,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics